GILEAD SCIENCES, INC.
GILDUS売上高
$29.4B
百万USD
営業利益
$10.0B
百万USD
純利益
$8.5B
百万USD
ROE
37.5%
最新FY
EPS
$6.78
USD / 株
配当
$3.16
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $6.4B | $1.7B | $1.37 |
| FY2021 | Q2 | $6.2B | $1.5B | $1.21 |
| FY2021 | Q3 | $7.4B | $2.6B | $2.05 |
| FY2021 | FY | $27.3B | $6.2B | $4.93 |
| FY2022 | Q1 | $6.6B | $19M | $0.02 |
| FY2022 | Q2 | $6.3B | $1.1B | $0.91 |
| FY2022 | Q3 | $7.0B | $1.8B | $1.42 |
| FY2022 | FY | $27.3B | $4.6B | $3.64 |
| FY2023 | Q1 | $6.4B | $1.0B | $0.80 |
| FY2023 | Q2 | $6.6B | $1.0B | $0.83 |
| FY2023 | Q3 | $7.1B | $2.2B | $1.73 |
| FY2023 | FY | $27.1B | $5.7B | $4.50 |
| FY2024 | Q1 | $6.7B | $-4.2B | $-3.34 |
| FY2024 | Q2 | $7.0B | $1.6B | $1.29 |
| FY2024 | Q3 | $7.5B | $1.3B | $1.00 |
| FY2024 | FY | $28.8B | $480M | $0.38 |
| FY2025 | Q1 | $6.7B | $1.3B | $1.04 |
| FY2025 | Q2 | $7.1B | $2.0B | $1.56 |
| FY2025 | Q3 | $7.8B | $3.1B | $2.43 |
| FY2025 | FY | $29.4B | $8.5B | $6.78 |
| FY2026 | Q1 | $7.0B | $2.0B | $1.61 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $22.1B | $22.4B | $24.7B | $27.3B | $27.3B | $27.1B | $28.8B | $29.4B |
| 営業利益 | $17.6B | $14.1B | $8.2B | $4.3B | $4.1B | $9.9B | $7.3B | $7.6B | $1.7B | $10.0B |
| 純利益 | $13.5B | $4.6B | $5.5B | $5.4B | $123M | $6.2B | $4.6B | $5.7B | $480M | $8.5B |
| 総資産 | $57.0B | $70.3B | $63.7B | $61.6B | $68.4B | $68.0B | $63.2B | $62.1B | $59.0B | $59.0B |
| 純資産 | $19.4B | $20.5B | $21.5B | $22.6B | $18.2B | $21.1B | $21.2B | $22.7B | $19.2B | $22.6B |
| 自己資本 | $18.9B | $20.4B | $21.4B | $22.5B | $18.2B | $21.1B | $21.2B | $22.8B | $19.3B | $22.7B |
| 営業CF | $16.7B | $11.9B | $8.4B | $9.1B | $8.2B | $11.4B | $9.1B | $8.0B | $10.8B | $10.0B |
| EPS | $9.94 | $3.51 | $4.17 | $4.22 | $0.10 | $4.93 | $3.64 | $4.50 | $0.38 | $6.78 |
| BPS | $14.45 | $15.60 | $16.77 | $17.83 | $14.49 | $16.80 | $17.03 | $18.33 | $15.52 | $18.29 |
| ROE | 71.5% | 22.6% | 25.5% | 23.9% | 0.7% | 29.5% | 21.6% | 24.8% | 2.5% | 37.5% |